Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy — M. Liontos (2021) | RDL Network
Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy
Article 2021 en
Authors
ML
M. Liontos
AA
A. Andrikopoulou
KK
Konstantinos Koutsoukos
Abstract
1 min read
NLR could serve as a useful predictor of OS but not PFS in ovarian cancer patients receiving NACT. In accordance with our previous study, CRS score at omentum was found to be associated with PFS but not OS in ovarian cancer patients treated with NACT and IDS.
Maria Kaparelou, Roubini Zakopoulou, Anna Tsiara, Anastasios Kyriazoglou, Michalis Liontos, G. P. Tsironis, K. Koutsoukos, Flora Zagouri, Dimitrios‐Efthymios Vlachos, Nikolaos Thomakos, Dimitrios Haidopoulos, Alexandros Rodolakis, Meletios A Dimopoulos, Aristotle Bamias
Discussion(0)
No comments yet. Be the first to comment.